Titel

Merkliste
1 Ergebnisse

Human mesenchymal stem cell therapy in severe COVID-19 pati..:

Tian-Tian Li ; Bo Zhang ; Hui Fang...
http://www.sciencedirect.com/science/article/pii/S2352396423001652. , 2023

Link: https://doi.org/10.1016/j.ebiom.2023.104600

RT Journal
T1 <Title>Human mesenchymal stem cell therapy in severe COVID-19 patients: 2-year follow-up results of a randomized, double-blind, placebo-controlled trialResearch in context</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:3b283893b18e47c5a4cb7e255aabc5e4&Exemplar=1&LAN=DE
				
A1 Tian-Tian Li
A1 Bo Zhang
A1 Hui Fang
A1 Ming Shi
A1 Wei-Qi Yao
A1 Yuanyuan Li
A1 Chao Zhang
A1 Jinwen Song
A1 Lei Huang
A1 Zhe Xu
A1 Xin Yuan
A1 Jun-Liang Fu
A1 Cheng Zhen
A1 Yu Zhang
A1 Ze-Rui Wang
A1 Zi-Ying Zhang
A1 Meng-Qi Yuan
A1 Tengyun Dong
A1 Ruidan Bai
A1 Lulu Zhao
A1 Jianming Cai
A1 Jinghui Dong
A1 Jianzeng Zhang
A1 Wei-Fen Xie
A1 Yonggang Li
A1 Lei Shi
A1 Fu-Sheng Wang
PB Elsevier
YR 2023
K1 COVID-19
K1 Mesenchymal stem cell
K1 2-year follow-up
K1 Medicine
K1 R
K1 Medicine (General)
K1 R5-920
JF http://www.sciencedirect.com/science/article/pii/S2352396423001652
LK http://dx.doi.org/https://doi.org/10.1016/j.ebiom.2023.104600
DO https://doi.org/10.1016/j.ebiom.2023.104600
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)